Chronic gout is the advanced stage of gout, where uric acid crystals have built up in your joints and soft tissues over months or years, causing persistent pain, visible lumps, and potential joint damage. Unlike the occasional gout flare that strikes and resolves, chronic gout means the disease is always present, even between attacks. If left untreated, up to 30% of people with acute gout develop chronic tophaceous gout within five years.
How Gout Becomes Chronic
Gout starts with high levels of uric acid in the blood. Your body produces uric acid when it breaks down certain compounds found in foods like red meat, shellfish, and alcohol. Normally, uric acid dissolves in the blood, passes through the kidneys, and leaves the body in urine. When levels stay elevated for too long, uric acid forms sharp, needle-like crystals that settle into joints.
Early gout typically shows up as sudden, intense flares, often in the big toe, that last a few days to a couple of weeks before fading completely. Between flares, you might feel perfectly fine. But if uric acid levels stay high, several things change. Flares start happening more frequently. They last longer. The pain between attacks never fully disappears. Crystal deposits begin accumulating in joints and surrounding tissue, triggering a constant low-grade inflammatory response. At this point, gout has shifted from an intermittent problem to a chronic disease.
Tophi: The Hallmark of Chronic Gout
The most distinctive sign of chronic gout is the formation of tophi, which are chalky lumps of uric acid crystals that grow under the skin. They commonly appear around the fingers, elbows, ears, Achilles tendon, and toes, though they can form in almost any joint or soft tissue. Small tophi may look like firm, whitish or yellowish nodules under the skin. Larger ones can become disfiguring and extremely painful.
Tophi form when immune cells called neutrophils swarm the uric acid crystals and essentially build a web of cellular material around them. Over time, these deposits harden and grow. They aren’t just cosmetic problems. Tophi erode cartilage and bone, gradually destroying the joints they surround. People with advanced tophaceous gout can lose significant mobility in their hands, feet, and other affected joints. In some cases, tophi break through the skin and drain a gritty, white paste.
What Chronic Gout Feels Like
People with chronic gout describe a baseline of stiffness and aching in affected joints that never fully goes away, punctuated by intense flares that feel like the joint is on fire. Even light pressure from bedsheets or socks can be unbearable during a flare. Joints may appear swollen, red, and warm to the touch.
Beyond the pain, chronic gout steadily limits what you can do. Gripping objects becomes difficult if tophi form in the fingers. Walking is painful when the feet or ankles are involved. Over years, the cumulative joint damage can look similar to severe osteoarthritis on imaging, with narrowed joint spaces and bone erosion. Chronic gout also raises the risk of kidney stones, since the same excess uric acid can crystallize in the kidneys.
How Chronic Gout Is Diagnosed
The gold standard for diagnosing gout is drawing fluid from an affected joint with a needle and examining it under a microscope for uric acid crystals. In practice, this happens in only about 17% of cases because it can be technically difficult, especially in small or deeply inflamed joints. Even when aspiration is performed during an acute flare, the test comes back negative roughly 25% of the time.
A specialized CT scan called dual-energy CT (DECT) has become an important alternative. It can detect uric acid deposits throughout the body without a needle, with 84% sensitivity and 93% specificity for gout. DECT is particularly useful for chronic gout because it can reveal crystal deposits in joints and tissues you wouldn’t think to test, showing the full extent of the disease. It can also pick up early, subclinical deposits before visible tophi form, which gives doctors a chance to start treatment sooner.
Blood tests measuring uric acid levels are helpful but not definitive on their own. Some people have high uric acid without gout, and uric acid levels can actually drop during an acute flare, making a single reading misleading.
The Goal of Treatment: Lowering Uric Acid
Managing chronic gout requires two separate strategies: controlling the pain of individual flares and, more importantly, lowering uric acid levels enough to dissolve existing crystals and prevent new ones from forming. Anti-inflammatory medications handle flares, but the real long-term treatment is urate-lowering therapy.
The target is getting blood uric acid below 6 mg/dL. At this level, existing crystals slowly dissolve over time, tophi shrink, and flares become less frequent. For people with large tophi, doctors sometimes aim even lower to speed up the process. Getting below that threshold and staying there is the single most important factor in reversing chronic gout.
The most commonly prescribed urate-lowering medications work by blocking the enzyme that produces uric acid. Treatment typically starts at a low dose and is gradually increased based on blood tests, because lowering uric acid too quickly can paradoxically trigger a flare. For this reason, doctors often prescribe an anti-inflammatory medication alongside urate-lowering therapy for the first several months as a preventive measure.
One counterintuitive aspect of treatment: you may actually experience more flares in the first few months after starting urate-lowering therapy. As crystals begin to dissolve, smaller fragments break free and irritate the joint lining. This is a sign the medication is working, not failing. Sticking with treatment through this phase is critical, because stopping and restarting creates a frustrating cycle of flares.
When Standard Treatment Isn’t Enough
Some people don’t respond adequately to standard urate-lowering medications, either because their uric acid remains stubbornly high or because they can’t tolerate the drugs. This is considered refractory chronic gout. The FDA has approved an injectable enzyme therapy specifically for these patients. It works by converting uric acid into a harmless compound the body can easily eliminate, and it can dramatically reduce tophi in people who have failed other options. In clinical trials, eligible patients had uric acid levels of at least 8 mg/dL, a history of three or more flares in the prior 18 months (or at least one tophus), and had not achieved adequate results with conventional therapy.
Lifestyle Changes That Make a Difference
Medication does the heavy lifting in chronic gout, but dietary and lifestyle changes support it. Limiting foods high in purines (organ meats, certain seafood, beer, and liquor) helps reduce the raw material your body uses to make uric acid. Staying well hydrated helps your kidneys flush uric acid more efficiently. Losing weight, if you’re carrying extra pounds, lowers uric acid levels independently of medication.
Chronic gout is closely linked to other metabolic conditions. High blood pressure, kidney disease, diabetes, and obesity all raise uric acid levels and make gout harder to control. Addressing these conditions improves gout outcomes and overall health simultaneously. Alcohol, particularly beer and spirits, is one of the strongest dietary triggers because it both increases uric acid production and impairs the kidneys’ ability to excrete it.
Chronic Gout Is Reversible With Consistent Treatment
The most important thing to understand about chronic gout is that it doesn’t have to be permanent. Unlike many forms of arthritis, gout is driven by a measurable, modifiable chemical imbalance. When uric acid stays below 6 mg/dL consistently, crystals dissolve, tophi shrink or disappear entirely, and flares stop. The process is slow, often taking a year or more for significant tophi to resolve, but the trajectory is toward healing rather than decline. The biggest barrier isn’t the disease itself but inconsistent treatment. People who stop taking their medication when they feel better almost always see the disease return and progress.